⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23018558 | 0.72 | — | — | |
| SCHEMBL2590463 | 0.69 | — | — | |
| SCHEMBL9299484 | 0.69 | — | — | |
| SCHEMBL28970800 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL10748496 | 0.67 | — | — | |
| SCHEMBL13888679 | 0.65 | — | — | |
| SCHEMBL5402230 | 0.65 | — | — | |
| SCHEMBL22317369 | 0.65 | — | — | |
| SCHEMBL2293158 | 0.62 | — | — | |
| SCHEMBL3776256 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110313147-A1 | CHROMATOGRAPHIC MATERIAL FOR THE ABSORPTION OF PROTEINS AT PHYSIOLOGICAL IONIC STRENGTH | PALL CORPORATION (US) | 2011-12-22 | — | — | US | disclosed |
| US-8021889-B2 | Chromatographic material for the absorption of proteins at physiological ionic strength | PALL CORPORATION (US) | 2011-09-20 | — | — | US | disclosed |
| US-20070151910-A1 | Chromatographic material for the absorption of proteins at physiological ionic strength | PALL CORPORATION (US) | 2007-07-05 | — | — | US | disclosed |
| EP-1715948-A2 | CHROMATOGRAPHIC MATERIAL FOR THE ABSORPTION OF PROTEINS AT PHYSIOLOGICAL IONIC STRENGTH | Pall Corporation (US) | 2006-11-02 | — | — | EP | disclosed |
| WO-2005073711-A2 | CHROMATOGRAPHIC MATERIAL FOR THE ABSORPTION OF PROTEINS AT PHYSIOLOGICAL IONIC STRENGTH | PALL CORPORATION (US) | 2005-08-11 | — | — | WO | disclosed |